Clinical trials
Monogenic Diabetes clinical trials
Below are recruiting monogenic diabetes clinical trials, each written for real people, not researchers. We’re tracking 7 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06746610Recruiting
Personalized management for inherited diabetes in young adults
This study looks for people with a type of diabetes that runs in families, often diagnosed at a young age. It uses genetic testing to find the exact cause and then tailor treatment to each person.
TianjinAges Any age - NCT03988764Recruiting
Checking monogenic diabetes wrongly labeled as type 1
This trial looks at people who were diagnosed with diabetes before age 25 as either type 1 or “not sure which type.” It may help confirm whether the cause is genetic (monogenic) rather than type 1, which can change treatment choices.
Montreal, QuebecAges 1 day–25 years - NCT06976658RecruitingPhase 2
Glucokinase Activator for GCK-MODY Diabetes
This trial tests an experimental pill (a glucokinase activator) in adults with a specific genetic form of diabetes called GCK-MODY. The study aims to see if the pill can help control blood sugar without causing dangerously low sugar levels.
Hong KongAges 18–74 - NCT07492004Recruiting
China Registry for Genetic Diabetes
This registry is for people who may have a genetic form of diabetes (monogenic diabetes) diagnosed at a young age. It collects information to better understand and diagnose these rare diabetes types.
TianjinAges Any age - NCT06478121Recruiting
Understanding how genes affect beta cells
This study looks at how specific genetic changes affect beta cells, which make insulin. It may help people with rare genetic forms of diabetes or other beta cell disorders, and also needs healthy volunteers for comparison.
Exeter, DevonAges 6–99 - NCT06065852Recruiting
National registry for rare kidney diseases
This study creates a registry to collect health information from people with rare kidney diseases. It aims to improve understanding and future treatments by tracking patient experiences.
Bristol, South WestAges Any age - NCT03835312Recruiting
Transplant plan for children with genetic immune problems and diabetes
This trial tests a two-step transplant approach using immune-related stem cells and islet (pancreas insulin–making) cells in children and teens who have type 1 diabetes caused by a genetic immune problem. It aims to improve insulin control and protect other organs that are being affected by their immune system.
Shanghai, Shanghai MunicipalityAges Up to 18 years
Hear when a new Monogenic Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for monogenic diabetes?
- Yes. Clin2 currently lists 7 recruiting monogenic diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a monogenic diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a monogenic diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.